Physician Assistant · Dothan, AL
NPI
1891361440
Since 2021
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
106 Westside Dr
Dothan, AL, 36303
Phone (877) 231-3376
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
1,642 services
Medicare patients, 2024
366
Average age 73
Drug cost, 2024
$1.6M
1,425 prescriptions
Company payments, 2025
$2,664
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tiffany Gerber was code 17003 (destruction skin lesion), 582 times for 100 patients. In total Tiffany Gerber billed 1,642 services in 29 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 582 | 100 | $3.21 | $1,869 |
| 99213 Office E&M - Established | Office | 194 | 144 | $47.96 | $9,304 |
| 17000 Destruction Skin Lesion | Office | 174 | 139 | $30.10 | $5,238 |
| 99212 Office E&M - Established | Office | 146 | 123 | $29.02 | $4,237 |
| 11102 Skin Biopsy | Office | 129 | 117 | $50.04 | $6,455 |
| 17110 Destruction Skin Lesion | Office | 62 | 56 | $60.34 | $3,741 |
| 11103 Skin Biopsy | Office | 50 | 34 | $25.97 | $1,299 |
| 99202 Office E&M - New | Office | 47 | 47 | $35.94 | $1,689 |
| 99203 Office E&M - New | Office | 46 | 46 | $61.18 | $2,814 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 43 | 13 | $0.76 | $32.55 |
| 99214 Office E&M - Established | Office | 24 | 20 | $65.13 | $1,563 |
| 17004 Destruction Skin Lesion | Office | 16 | 12 | $94.88 | $1,518 |
| 11900 Skin | Office | 15 | 12 | $24.40 | $366 |
| 11200 Removal or Shaving of Skin Growth | Office | 13 | 13 | $36.73 | $477 |
By year: 2022 $39K for 812 services; 2023 $33K for 932 services; 2024 $49K for 1,642 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tiffany Gerber prescribed most often to Medicare patients was Ketoconazole, with 299 prescriptions and refills. In total Tiffany Gerber wrote 1,425 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 299 | 306 | 115 | $5,767 |
| Triamcinolone Acetonide Generic | 116 | 127 | 70 | $2,016 |
| Clobetasol Propionate Generic | 96 | 103 | 51 | $5,739 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 80 | 80 | 26 | $6,088 |
| Mupirocin Generic | 77 | 81 | 38 | $808 |
| Betamethasone Dipropionate Generic | 57 | 58 | 37 | $3,217 |
| Doxycycline Hyclate Generic | 53 | 62 | 29 | $1,373 |
| Cosentyx Unoready Pen Secukinumab | 50 | 50 | Under 11 | $404K |
| Hydrocortisone Generic | 50 | 50 | 28 | $427 |
| Hydroxyzine Hcl Generic | 47 | 49 | 19 | $495 |
| Humira(Cf) Pen Adalimumab | 38 | 38 | Under 11 | $398K |
| Ammonium Lactate Generic | 35 | 51 | 21 | $888 |
| Finasteride Generic | 29 | 46 | Under 11 | $165 |
| Tacrolimus Generic | 25 | 27 | 18 | $3,045 |
| Dupixent Pen Dupilumab | 23 | 23 | Under 11 | $86K |
Brand drugs: 216 claims; generic drugs: 1,209 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tiffany Gerber $2,664 ($2,664 in general payments such as food, travel and fees) from 17 companies. The largest payer was Janssen Biotech, Inc. with $552.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 25 | $552 |
| Abbvie Inc. ABBV | 17 | $429 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $416 |
| UCB, Inc. UCB.BR | 31 | $321 |
| Genzyme Corporation SNY | 9 | $239 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $155 |
| Pfizer Inc. PFE | 7 | $107 |
| Incyte Corporation INCY | 5 | $91.22 |
| Organogenesis Inc. ORGO | 5 | $86.4 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $53.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.